# Pregnancy & Exposure, Including Substance Use

## Overview of Instruments
#### Pregnancy & Infant Health
<table style="width: 100%; border-collapse: collapse; table-layout: fixed; font-size: 14px;">
    <thead>
      <tr>
        <th style="width: 30%; padding: 8px; text-align: center;">Name of Instrument</th>
        <th style="width: 20%; padding: 8px; text-align: center;">Acronym</th>
        <th style="width: 30%; padding: 8px; text-align: center;">Construct</th>
        <th style="width: 20%; padding: 8px; text-align: center;">Table Name</th>
      </tr>
    </thead>
<tbody>
 <tr>
        <td style="padding: 8px; word-wrap: break-word; white-space: normal;"><a href="#instrument-details">Pregnancy Health</a></td>
        <td style="padding: 8px; word-wrap: break-word; white-space: normal;">Healthhx</td>
        <td style="padding: 8px; word-wrap: break-word; white-space: normal;">Pre-pregnancy and pregnancy health</td>
        <td style="padding: 8px; word-wrap: break-word; white-space: normal;">pex_bm_health_preg__healthhx</td>
    </tr>          
    <tr>
        <td style="padding: 8px; word-wrap: break-word; white-space: normal;"><a href="#instrument-details">Pregnancy Health-Exposures and Vaccines</a></td>
        <td style="padding: 8px; word-wrap: break-word; white-space: normal;">Vacc</td>
        <td style="padding: 8px; word-wrap: break-word; white-space: normal;">Vaccines in pregnancy</td>
        <td style="padding: 8px; word-wrap: break-word; white-space: normal;">pex_bm_health_preg__exp__vacc</td>
    </tr>    
    <tr>
        <td style="padding: 8px; word-wrap: break-word; white-space: normal;"><a href="#instrument-details">Pregnancy Health-Chronic Conditions</a></td>
        <td style="padding: 8px; word-wrap: break-word; white-space: normal;">Exp I chroncond</td>
        <td style="padding: 8px; word-wrap: break-word; white-space: normal;">Chronic conditions and sexually transmitted infections in pregnancy</td>
        <td style="padding: 8px; word-wrap: break-word; white-space: normal;">pex_bm_health_preg__chroncond</td>
    </tr>  
    <tr>
        <td style="padding: 8px; word-wrap: break-word; white-space: normal;"><a href="#instrument-details">Pregnancy Health-Illness</a></td>
        <td style="padding: 8px; word-wrap: break-word; white-space: normal;">Exp I illness</td>
        <td style="padding: 8px; word-wrap: break-word; white-space: normal;">Illness in pregnancy</td>
        <td style="padding: 8px; word-wrap: break-word; white-space: normal;">pex_bm_health_preg__illness</td>
    </tr>     
    <tr>
        <td style="padding: 8px; word-wrap: break-word; white-space: normal;"><a href="#instrument-details">Pregnancy Health-ER/Hospitalizations</a></td>
        <td style="padding: 8px; word-wrap: break-word; white-space: normal;">Exp I ERhosp</td>
        <td style="padding: 8px; word-wrap: break-word; white-space: normal;">ER visit or hospitalization in pregnancy</td>
        <td style="padding: 8px; word-wrap: break-word; white-space: normal;">pex_bm_health_preg__erhosp</td>
    </tr>  
    <tr>
        <td style="padding: 8px; word-wrap: break-word; white-space: normal;"><a href="#instrument-details">Pregnancy Health-Medications</a></td>
        <td style="padding: 8px; word-wrap: break-word; white-space: normal;">Exp I Meds</td>
        <td style="padding: 8px; word-wrap: break-word; white-space: normal;">Prescription and over the counter medications in pregnancy</td>
        <td style="padding: 8px; word-wrap: break-word; white-space: normal;">pex_bm_health_preg__meds</td>
    </tr>  
    <tr>
        <td style="padding: 8px; word-wrap: break-word; white-space: normal;"><a href="#instrument-details">Pregnancy Health-V2 (End of Pregnancy)</a></td>
        <td style="padding: 8px; word-wrap: break-word; white-space: normal;">Healthv2 Preg</td>
        <td style="padding: 8px; word-wrap: break-word; white-space: normal;">Updates information between enrollment and delivery</td>
        <td style="padding: 8px; word-wrap: break-word; white-space: normal;">pex_bm_healthv2_preg</td>
    </tr>     
    <tr>
        <td style="padding: 8px; word-wrap: break-word; white-space: normal;"><a href="#instrument-details">Infant health- V2</a></td>
        <td style="padding: 8px; word-wrap: break-word; white-space: normal;">Healthv2 Inf</td>
        <td style="padding: 8px; word-wrap: break-word; white-space: normal;">Delivery and birth outcomes</td>
        <td style="padding: 8px; word-wrap: break-word; white-space: normal;">pex_bm_healthv2_inf</td>
    </tr>   
</tbody>
</table>

#### Mental Health
<table style="width: 100%; border-collapse: collapse; table-layout: fixed; font-size: 14px;">
    <thead>
      <tr>
        <th style="width: 30%; padding: 8px; text-align: center;">Name of Instrument</th>
        <th style="width: 20%; padding: 8px; text-align: center;">Acronym</th>
        <th style="width: 30%; padding: 8px; text-align: center;">Construct</th>
        <th style="width: 20%; padding: 8px; text-align: center;">Table Name</th>
      </tr>
    </thead>
<tbody>
    <tr>
        <td style="padding: 8px; word-wrap: break-word; white-space: normal;"><a href="#personal-family-psychiatric-history">Personal and family psychiatric history</a></td>
        <td style="padding: 8px; word-wrap: break-word; white-space: normal;">FAM MH</td>
        <td style="padding: 8px; word-wrap: break-word; white-space: normal;">Personal and family mental health</td>
        <td style="padding: 8px; word-wrap: break-word; white-space: normal;">pex_bm_psych</td>
    </tr>            
    <tr>
        <td style="padding: 8px; word-wrap: break-word; white-space: normal;"><a href="#apa-12">DSM-5 Self-Rated Level 1 and Level 2 (version 8a) Cross-Cutting Symptom Measure—Adult</a></td>
        <td style="padding: 8px; word-wrap: break-word; white-space: normal;">APA 1/2</td>
        <td style="padding: 8px; word-wrap: break-word; white-space: normal;">Mental Health</td>
        <td style="padding: 8px; word-wrap: break-word; white-space: normal;">pex_bm_apa</td>
    </tr>  
    <tr>
        <td style="padding: 8px; word-wrap: break-word; white-space: normal;"><a href="#dsm5-ptsdacute-stress-short-scale">National Stressful Events Survey- PTSD Short Scale/Acute Stress Disorder</a></td>
        <td style="padding: 8px; word-wrap: break-word; white-space: normal;">NSESSS—PTSD/Acute Stress Disorder</td>
        <td style="padding: 8px; word-wrap: break-word; white-space: normal;">PTSD/acute stress disorder symptom severity</td>
        <td style="padding: 8px; word-wrap: break-word; white-space: normal;">pex_bm_str__ptsd</td>
    </tr>      
    <tr>
        <td style="padding: 8px; word-wrap: break-word; white-space: normal;"><a href="#epds">Edinburgh Postnatal Depression Scale</a></td>
        <td style="padding: 8px; word-wrap: break-word; white-space: normal;">EPDS</td>
        <td style="padding: 8px; word-wrap: break-word; white-space: normal;">Postnatal depression</td>
        <td style="padding: 8px; word-wrap: break-word; white-space: normal;">pex_bm_epds</td>
    </tr>      
</tbody>
</table>


## Implementation & Data Collection
Surveys were translated to Spanish for HBCD by [BURG Translations](https://burgtranslations.com/our-services/). All of the instruments are child-unspecific with the exception of **Healthv2 Inf**. Additional information is as follows:

<table style="width: 100%; border-collapse: collapse; table-layout: fixed; font-size: 15px;">
<tfoot><tr><td colspan="5" style="word-wrap: break-word; white-space: normal;"><b class="blue-text">**</b> <i>All substance use instruments were administered in-person except in Alabama, where participants were trained to self-administer.</i></td></tr></tfoot>
    <thead>
      <tr>
        <th style="width: 30%; padding: 8px; text-align: center;">Instrument</th>
        <th style="width: 10%; padding: 8px; text-align: center;"><span class="tooltip tooltip-right">Respondant
                <span class="tooltiptext"><br><br>1 - pregnant person<br>2 - person who gave birth<br>3 - primary caregiver</a></span>
              </span></th>
        <th style="width: 30%; padding: 8px; text-align: center;">Administration</th>
        <th style="width: 10%; padding: 8px; text-align: center;">Visits</th>
        <th style="width: 10%; padding: 8px; text-align: center;">Completion Time</th>
      </tr>
    </thead>
<tbody>
    <tr>
        <td style="padding: 8px; word-wrap: break-word; white-space: normal;">Pregnancy Health</td>
        <td>1</td>
        <td>Self</td>
        <td>V01</td>
        <td>5 min</td>
    </tr>    
    <tr>
        <td style="padding: 8px; word-wrap: break-word; white-space: normal;">Pregnancy Health-Exposures and Vaccines</td>
        <td>1</td>
        <td>Self</td>
        <td>V01</td>
        <td>3 min</td>
    </tr>      
    <tr>
        <td style="padding: 8px; word-wrap: break-word; white-space: normal;">Pregnancy Health-Chronic Conditions</td>
        <td>1</td>
        <td>Self (in person)</td>
        <td>V01</td>
        <td>3 min</td>
    </tr>      
    <tr>
        <td style="padding: 8px; word-wrap: break-word; white-space: normal;">Pregnancy Health-Illness</td>
        <td>1</td>
        <td>HBCD Study Staff (in-person)</td>
        <td>V01</td>
        <td>3 min</td>
    </tr>          
    <tr>
        <td style="padding: 8px; word-wrap: break-word; white-space: normal;">Pregnancy Health-ER</td>
        <td>1</td>
        <td>HBCD Study Staff (in-person)</td>
        <td>V01</td>
        <td>5 min</td>
    </tr>       
    <tr>
        <td style="padding: 8px; word-wrap: break-word; white-space: normal;">Pregnancy Health-Medications</td>
        <td>1</td>
        <td>HBCD Study Staff (in-person)</td>
        <td>V01</td>
        <td>5 min</td>
    </tr>       
    <tr>
        <td style="padding: 8px; word-wrap: break-word; white-space: normal;">Pregnancy Health-V2</td>
        <td>2</td>
        <td>HBCD Study Staff (in-person)</td>
        <td>V02</td>
        <td>10 min</td>
    </tr>     
    <tr>
        <td style="padding: 8px; word-wrap: break-word; white-space: normal;">Healthv2 Inf</td>
        <td>2/3</td>
        <td>HBCD Study Staff (in-person)</td>
        <td>V02</td>
        <td>10 min</td>
    </tr>       
    <tr>
        <td style="padding: 8px; word-wrap: break-word; white-space: normal;">FAM MH</td>
        <td>1</td>
        <td>Self (in-person)</td>
        <td>V01</td>
        <td>5 min</td>
    </tr>       
    <tr>
        <td>APA 1/2</td>
        <td style="word-wrap: break-word; white-space: normal;">1/2/3</td>
        <td>Self (in-person or remote)</td>
        <td>V01, V02, V03</td>
        <td>5 min</td>
    </tr>    
    <tr>
        <td style="word-wrap: break-word; white-space: normal;">NSESSS—PTSD/Acute Stress Disorder</td>
        <td style="word-wrap: break-word; white-space: normal;">1/2/3</td>
        <td>Self (in-person or remote)</td>
        <td>V01, V02, V03</td>
        <td>3 min</td>
    </tr>       
    <tr>
        <td>EPDS</td>
        <td>1/2</td>
        <td>Self (in-person or remote)</td>
        <td>V01, V02, V03</td>
        <td>3 min</td>
    </tr>   
    <tr>
        <td>Assist V1</td>
        <td>1</td>
        <td>HBCD Study Staff (in-person)<b class="blue-text">**</b></td>
        <td>V01</td>
        <td>5 min</td>
    </tr>     
    <tr>
        <td>Assist V2</td>
        <td>2</td>
        <td>HBCD Study Staff (in-person)<b class="blue-text">**</b></td>
        <td>V02</td>
        <td>5 min</td>
    </tr>     
    <tr>
        <td>Assist V3</td>
        <td>2/3</td>
        <td>HBCD Study Staff (in-person)<b class="blue-text">**</b></td>
        <td>V03</td>
        <td>3 min</td>
    </tr>        
    <tr>
        <td>TLFB</td>
        <td>2/3</td>
        <td>HBCD Study Staff (in-person)<b class="blue-text">**</b></td>
        <td>V01, V02</td>
        <td>10 min</td>
    </tr>              
</tbody>
</table>

## Quality Control
For all instruments, quality control was performed by reviewing response distributions for outliers. Substance use instruments were additionally cross-checked between the TLFB and ASSIST V1/V2 to ensure consistency in reported substances. One common issue was that reported substances used on the TLFB were not always noted on the Assist V1/V2, which triggered a query to the site to correct it.

## Pregnancy & Infant Health

<div id="alert" class="alert-banner" onclick="toggleCollapse(this)">
  <span class="emoji"><i class="fas fa-exclamation-circle"></i></span>
  <span class="text-with-link">
  <span class="text">Responsible Use Warning: <i>Pregnancy Health</i></span>
  <a class="anchor-link" href="#alert" title="Copy link">
  <i class="fa-solid fa-link"></i>
  </a>
  </span>
  <span class="arrow">▸</span>
</div>
<div class="alert-collapsible-content">
<p style="margin-bottom: 5px; padding-bottom: 5px; border-bottom: 1px solid #6b6b6b66;"><strong>Pregnancy Health (<code>Healthhx</code>): Pregnancy intention as a determinant of exposure</strong></p>
<p>Amidst powerful societal expectations to ‘do what’s best for the baby’ during pregnancy (i.e. by stopping substance use), up to half of pregnancies in the United States are unintended with 1 in 5 unwanted (<a href="https://doi.org/10.1016/S2214-109X(20)30315-6">Bearak et al. 2020</a>). This discrepancy contributes to implicit bias against pregnant individuals who use substances as ‘not caring about their babies’ which is neither humane, nor evidence based (Massey et al., 2022). While cessation of substance use during pregnancy is universally recognized as optimal, the ability to make this “parental” sacrifice varies substantially between birthing individuals and within individuals between their different pregnancies (Level et al., 2024). Failure to recognize this inherent heterogeneity in pregnancy intention stigmatizes substance users who did not intend to want to become pregnant. Summarily, inclusion of pregnancy intention as a covariate in all studies that characterize prenatal substance exposure (in the absence of a strong justification otherwise) is thus strongly recommended to acknowledge myriad experiences of birthing parents who participated in HBCD who made this research possible.</p>
</div>

<p>
<div id="warning" class="warning-banner" onclick="toggleCollapse(this)">
    <span class="emoji"><i class="fas fa-exclamation-triangle"></i></span>
  <span class="text-with-link">
  <span class="text">Data Warnings</i></span>
  <a class="anchor-link" href="#warning" title="Copy link">
  <i class="fa-solid fa-link"></i>
  </a>
  </span>
  <span class="arrow">▸</span>
</div>
<div class="warning-collapsible-content">
<p style="margin-bottom: 5px; padding-bottom: 5px; border-bottom: 1px solid #6b6b6b66;"><b>Infant Health-V2 Out of Range Values</b></p>
<p>Please note that out-of-range values were filtered (i.e. changed to "n/a") for Healthv2 Inf (<code>pex_bm_healthv2_inf</code>). Valid field values are documented in <a href="../../../datacuration/exclusions#filtered-values">Filtered Out-Of-Range Field Values</a> under the section on <a href="../../../datacuration/exclusions">Exclusion Criteria</a>.</p>

<p style="margin-bottom: 5px; padding-bottom: 5px; border-bottom: 1px solid #6b6b6b66;"><b>ICD, Symptom, & Medication Coding</b></p>
<p>Subject matter experts note that there are potential issues relating to correct coding for (1) ICD codes from BioPortal ICD (used to capture reason(s) for medication use, ER visits, and hospitalizations), (2) symptom codes from World Health Organization, and (3) medication names from RxNORM. For instruments utilizing these coding systems, it was at times difficult for the participant to name or HBCD Study team member conducting the survey to find the correct code/name in a databases. The following instruments were impacted:</p> 
 <table style="width: 100%; border-collapse: collapse; table-layout: fixed;">
  <thead>
    <tr>
      <th style="border: 1px solid #ddd; padding: 8px; text-align: left;">Instrument</th>
      <th style="border: 1px solid #ddd; padding: 8px; text-align: left;">Database</th>
      <th style="border: 1px solid #ddd; padding: 8px; text-align: left;">Additional Notes</th>
    </tr>
  </thead>
<tbody>          
    <tr>
        <td style="border: 1px solid #ddd; padding: 8px; word-wrap: break-word; white-space: normal;">Pregnancy Health-Illness</td>
        <td>BioPortal & WHO</td>
        <td style="border: 1px solid #ddd; padding: 8px; word-wrap: break-word; white-space: normal;"><small>Coding difficulty noted for use of the ER for normal care (no diagnosis) or false alarms (e.g. thought water broke but it did not), resulting in the use of ‘don’t know.’</small></td>
    </tr>     
    <tr>
        <td style="border: 1px solid #ddd; padding: 8px; word-wrap: break-word; white-space: normal;">Pregnancy Health-ER/Hospitalizations</td>
        <td>BioPortal</td>
        <td style="border: 1px solid #ddd; padding: 8px; word-wrap: break-word; white-space: normal;"><small>None</small></td>
    </tr>  
    <tr>
        <td style="border: 1px solid #ddd; padding: 8px; word-wrap: break-word; white-space: normal;">Pregnancy Health-Medications</td>
        <td>RxNORM</td>
        <td style="border: 1px solid #ddd; padding: 8px; word-wrap: break-word; white-space: normal;"><small>No option for preventive use made it difficult to code aspirin use for preeclampsia. Aspirin was specifically moved to the prenatal vitamin section a few months into the study. Some medications were also coded with dose, but this was not asked and should not be used.</small></td>
    </tr>  
    <tr>
        <td style="border: 1px solid #ddd; padding: 8px; word-wrap: break-word; white-space: normal;">Pregnancy Health-V2 (End of Pregnancy)</td>    
        <td>BioPortal & RxNORM</td>
        <td style="border: 1px solid #ddd; padding: 8px; word-wrap: break-word; white-space: normal;"><small>None</small></td>
    </tr>     
    <tr>
        <td style="border: 1px solid #ddd; padding: 8px; word-wrap: break-word; white-space: normal;">Infant health- V2</td>
        <td>BioPortal & RxNORM</td>
        <td style="border: 1px solid #ddd; padding: 8px; word-wrap: break-word; white-space: normal;"><small>None</small></td>
    </tr>   
</tbody>
</table>
</div>
</p>

 <table style="width: 100%; border-collapse: collapse; table-layout: fixed;">
  <thead>
    <tr>
      <th style="border: 1px solid #ddd; padding: 8px; text-align: left;">Instrument</th>
      <th style="border: 1px solid #ddd; padding: 8px; text-align: left;">Information Collected</th>
    </tr>
  </thead>
<tbody>   
    <tr>
        <td style="border: 1px solid #ddd; padding: 8px; word-wrap: break-word; white-space: normal;">Pregnancy Health</td>
        <td style="border: 1px solid #ddd; padding: 8px; word-wrap: break-word; white-space: normal;">Gravidity and parity, height and weight, pregnancy intentions, use of assisted reproductive technology, start of prenatal care, prenatal vitamin or aspirin use, and secondhand smoke</td>
    </tr>          
    <tr>
        <td style="border: 1px solid #ddd; padding: 8px; word-wrap: break-word; white-space: normal;">Pregnancy Health-Exposures and Vaccines</td>
        <td style="border: 1px solid #ddd; padding: 8px; word-wrap: break-word; white-space: normal;">Receipt of common vaccines in pregnancy and trimester received</td>
    </tr>    
    <tr>
        <td style="border: 1px solid #ddd; padding: 8px; word-wrap: break-word; white-space: normal;">Pregnancy Health-Chronic Conditions</td>
        <td style="border: 1px solid #ddd; padding: 8px; word-wrap: break-word; white-space: normal;">Chronic conditions and sexually transmitted infections in pregnancy, including whether they are ongoing or resolved</td>
    </tr>  
    <tr>
        <td style="border: 1px solid #ddd; padding: 8px; word-wrap: break-word; white-space: normal;">Pregnancy Health-Illness</td>
        <td style="border: 1px solid #ddd; padding: 8px; word-wrap: break-word; white-space: normal;">Covid-19 or other illnesses in pregnancy, including start and stop dates and whether the person had a fever</td>
    </tr>     
    <tr>
        <td style="border: 1px solid #ddd; padding: 8px; word-wrap: break-word; white-space: normal;">Pregnancy Health-ER/Hospitalizations</td>
        <td style="border: 1px solid #ddd; padding: 8px; word-wrap: break-word; white-space: normal;">Occurrence(s) and reason(s) for ER visit(s) or hospitalization(s) during pregnancy</td>
    </tr>  
    <tr>
        <td style="border: 1px solid #ddd; padding: 8px; word-wrap: break-word; white-space: normal;">Pregnancy Health-Medications</td>
        <td style="border: 1px solid #ddd; padding: 8px; word-wrap: break-word; white-space: normal;">Medications (prescription or over-the-counter) used since last menstrual period (name, indication, frequency, and start/stop date)</td>
    </tr>  
    <tr>
        <td style="border: 1px solid #ddd; padding: 8px; word-wrap: break-word; white-space: normal;">Pregnancy Health-V2 (End of Pregnancy)</td>    
        <td style="border: 1px solid #ddd; padding: 8px; word-wrap: break-word; white-space: normal;">Updates on prenatal vitamins, aspirin, infections, vaccines, medications (both ongoing and new), and illnesses. Also covers pregnancy complications (e.g., gestational diabetes), labor details, delivery method, place of delivery, and the length of hospital stay.</td>
    </tr>     
    <tr>
        <td style="border: 1px solid #ddd; padding: 8px; word-wrap: break-word; white-space: normal;">Infant health- V2</td>
        <td style="border: 1px solid #ddd; padding: 8px; word-wrap: break-word; white-space: normal;">Infant birth weight, length, hospital stay duration, newborn conditions (e.g. neonatal abstinence syndrome), birth defects, genetic diagnoses, NICU admission and stay, intubation, adverse outcomes (e.g. BPD, congenital syphilis), medications (name, indication, status), healthcare access, specialist visits, and newborn hearing test results</td>
    </tr>   
</tbody>
</table>

## Mental Health
### Personal & Family Psychiatric History 
The HBCD FAM MH assesses self-reported diagnoses and mental health conditions of the biological mother, biological father, and biological maternal and paternal grandmother and grandfather. It was created from combining and modifying items from the [Family History Assessment Module (FHAM)](https://arc.psych.wisc.edu/self-report/family-history-assessment-module-fham/) and the [All of Us Personal and Family Health History](https://www.researchallofus.org/wp-content/themes/research-hub-wordpress-theme/media/2023/PaFHH_Survey_English.pdf). The HBCD FAM MH includes (1) FHAM items on alcohol use [alc], drug use [drug], depression [dep], mania [man], and Schizophrenia [sch]; and (2) All of Us mental health outcomes for only biological mother [bm] and biological father [bf]: Alcohol Use Disorder [001], Anxiety disorder or panic disorder [002], Autism Spectrum Disorder [003], Bipolar disorder [004], Depressive disorder [005], Drug or Substance Use Disorder [006], Schizophrenia [007], and Attention Deficit/Hyperactivity Disorder (ADHD) [008], excluding questions about age of diagnosis, treatment, and medications. Future publications should note that this measure is a combination of these and that this is not a scored scale, but simply descriptive for family psychiatric history.

<p>
<div id="table-banner" class="table-banner" onclick="toggleCollapse(this)">
  <span>
    <span class="text">HBCD Modification Details</span>
  </span>
  <span class="notification-arrow">▸</span>
</div>
<div class="closed-collapsible-content">
<p><b>FHAM</b></p>
<p>FAM MH excludes the following FHAM items: (1) items for Antisocial Personality Disorder [ASP] and Undifferentiated Psychiatric Disorder [UPD] and (2) items asking about any treatment for mental or emotional problems, hospitalization, and suicide. In addition, the original response options including 'parents', 'grandparents', 'siblings', 'aunts', 'uncles', and 'cousins' were modified to include only biological mom [001], biological dad [002], biological maternal grandmother [003], biological maternal grandfather [004], biological paternal grandmother [005], and biological paternal grandfather [006].</p>
<p><b>All of Us</b></p>
<p>Original response options including 'mom', 'dad', 'sibling', 'daughter', 'son', and 'grandparent' were modified to include only biological mother [bm] and biological father [bf]. Follow-up questions about age of diagnosis, treatment, and medications were excluded.</p>
</div>
</p>

### APA 1/2
<p>
<div id="apa-warning" class="warning-banner" onclick="toggleCollapse(this)">
  <span class="emoji"><i class="fas fa-exclamation-triangle"></i></span>
  <span class="text">Data Warning</span>
  <span class="arrow">▸</span>
</div>
<div class="warning-collapsible-content">
<p style="margin-bottom: 5px; padding-bottom: 5px; border-bottom: 1px solid #6b6b6b66;"><strong>Consideration of Mental Health Symptoms Experienced During Pregnancy</strong></p>
<p>Concurrence of psychiatric symptoms and substance use is well-recognized during pregnancy (Massey et al., 2011, 2012). Phenotypic risk in birthing parents may influence neurodevelopmental outcomes via prenatal and postnatal influences other than direct exposures alone (Estabrook et al., 2016, Massey et al., 2016, Massey et al., 2018). These influences may confound exposure-related neuroimaging and neurodevelopmental findings, and also represent malleable targets for prevention and early intervention. Thus, consideration of mental health symptoms experienced by birthing parents as covariates is strongly encouraged when possible to address these confounds.</p> 
</div>
</p>

The DSM-5 Self-Rated Level 1 and Level 2 Cross-Cutting Symptom Measure (APA 1/2) was adapted for HBCD by combining the following measures: the [DSM-5 Self-Rated Level 1 Cross-Cutting Symptom Measure—Adult](https://www.psychiatry.org/getmedia/e0b4b299-95b3-407b-b8c2-caa871ca218d/APA-DSM5TR-Level1MeasureAdult.pdf) and the [DSM-5 Level 2 Cross-Cutting Symptom Measures](https://www.psychiatry.org/psychiatrists/practice/dsm/educational-resources/assessment-measures):

![](images/DSM-5Level2Cross-CuttingSymptomMeasures.png)

**Level 1** includes 1-2 questions for each of eleven mental health domains, with scores calculated for depression, anger, mania, anxiety, somatic symptoms, suicidal ideation, psychosis, sleep disturbance, memory, repetitive behaviors, and dissociation. Note that Level 1 items for personality functioning and substance use were excluded. See Level 1 scoring procedures [here](https://www.psychiatry.org/getmedia/e0b4b299-95b3-407b-b8c2-caa871ca218d/APA-DSM5TR-Level1MeasureAdult.pdf). If symptoms are reported in Level 1, participants are subsequently administered the corresponding Level 2 symptom measure associated with each mental health domain, including anger, anxiety, depression, mania, somatic symptoms, repetitive thoughts, and sleep problems.

**Level 2** measures include all [Level 2 Cross-Cutting Symptom Measures](https://www.psychiatry.org/psychiatrists/practice/dsm/educational-resources/assessment-measures) with the exception of Substance Abuse. The Level 2 measures for Depression and Sleep Disturbance were replaced with the **PROMIS Short Forms v1.0** [Depression 8a questionnaire](https://www.phenxtoolkit.org/toolkit_content/supplemental_info/psychiatric/measures/07_Depressed_Mood.doc) and [Sleep Disturbance 8a](https://heal.nih.gov/files/CDEs/2024-07/promis-sleep-disturbance-8a-crf.pdf). Documentation for each measure and its scoring can be found [here](https://www.psychiatry.org/psychiatrists/practice/dsm/educational-resources/assessment-measures). PROMIS scoring procedures for Depression can be found [here](https://www.healthmeasures.net/images/PROMIS/manuals/Scoring_Manual_Only/PROMIS_Depression_Scoring_Manual_05Dec2023.pdf) and for Sleep Disturbance can be found [here](https://www.healthmeasures.net/images/PROMIS/manuals/Scoring_Manual_Only/PROMIS_Sleep_Scoring_Manual.pdf).

Finally, the HBCD measure also integrates the [Personality Inventory for DSM-5 Brief](https://www.psychiatry.org/File%20Library/Psychiatrists/Practice/DSM/APA_DSM5_The-Personality-Inventory-For-DSM-5-Brief-Form-Adult.pdf), which assesses five personality trait domains including negative affect, detachment, antagonism, disinhibition, and psychoticism. Scoring for the Personality Inventory can be found [here](https://www.psychiatry.org/File%20Library/Psychiatrists/Practice/DSM/APA_DSM5_The-Personality-Inventory-For-DSM-5-Brief-Form-Adult.pdf).

Additional modifications are described below. Future publications should be sure to acknowledge the removal of Level 1 and 2 substance use and the gating mechanisms for somatic symptoms and personality inventory:

<p>
<div id="table-banner" class="table-banner" onclick="toggleCollapse(this)">
  <span>
    <span class="text">HBCD Modification Details</span>
  </span>
  <span class="notification-arrow">▸</span>
</div>
<div class="closed-collapsible-content">
<br>
<p style="font-size: 1em; margin: 0 0 5px;"><b>Excluded Questions and Gating</b></p>
<p>Slight modifications were made due to the use of other measures and the study population. Specifically, the Level 1 questions for substance use and personality functioning were not included. Also, all participants answer the level 1 questions on depression and somatic symptoms but proceed to level 2 questions irrespective of answers; all participants proceed automatically to the level 2 measure for personality inventory.</p>

<p style="font-size: 1em; margin: 0 0 5px;"><b>Clinical Alerts</b></p>
<p>For HBCD, this measure was modified to alert study staff if responses to the Level 1 APA self-harm question ('Thoughts of actually hurting yourself?') or Level 2 APA depression questionnaire (items from 'I felt worthless' to 'I felt that nothing could cheer me up') exceed thresholds of 0 and 32, respectively.</p>

<p style="font-size: 1em; margin: 0 0 5px;"><b>Response Option Changes</b></p>
<p>For HBCD, the response option ‘Decline to answer’ was added to all questions. The response option ‘Don’t know’ was also included at the beginning of data collection, but was subsequently removed. Note that this does not impact scoring as questions answered with ‘Decline to answer’ or ‘Don’t know’ are skipped and marked as missing.</p> 

<p>Note that in early data releases, total scores are not calculated for Level 2 measures. Users are encouraged to score individual scales themselves according to the scoring procedures linked above.</p>
</div>
</p>



## References

<div class="references">
<p style="margin-bottom: 0; padding-bottom: 0;"><u>Pregnancy & Infant Health</u></p>
    <p>Bearak, J., Popinchalk, A., Ganatra, B., Moller, A.-B., Tunçalp, Ö., Beavin, C., Kwok, L., & Alkema, L. (2020). Unintended pregnancy and abortion by income, region, and the legal status of abortion: estimates from a comprehensive model for 1990-2019. The Lancet. Global Health, 8(9), e1152–e1161. <a href="https://doi.org/10.1016/S2214-109X(20)30315-6">https://doi.org/10.1016/S2214-109X(20)30315-6</a></p>
    <p>Massey, S. H., Neiderhiser, J. M., Shaw, D. S., Leve, L. D., Ganiban, J. M., & Reiss, D. (2012). Maternal self concept as a provider and cessation of substance use during pregnancy. Addictive Behaviors, 37(8), 956–961. <a href="https://doi.org/10.1016/j.addbeh.2012.04.002">https://doi.org/10.1016/j.addbeh.2012.04.002</a></p>
    <p>Massey, S. H., Estabrook, R., Lapping-Carr, L., Newmark, R. L., Decety, J., Wisner, K. L., & Wakschlag, L. S. (2022). Are empathic processes mechanisms of pregnancy’s protective effect on smoking? Identification of a novel target for preventive intervention. Social Science & Medicine (1982), 305(115071), 115071. <a href="https://doi.org/10.1016/j.socscimed.2022.115071">https://doi.org/10.1016/j.socscimed.2022.115071</a></p>
    <p>Schoenaker, D. A. J. M., Ploubidis, G. B., Goodman, A., & Mishra, G. D. (2017). Factors across the life course predict women’s change in smoking behaviour during pregnancy and in midlife: results from the National Child Development Study. Journal of Epidemiology and Community Health, 71(12), 1137–1144. <a href="https://doi.org/10.1136/jech-2017-209493">https://doi.org/10.1136/jech-2017-209493</a></p>
</div>


<div class="references">
<p style="margin-bottom: 0; padding-bottom: 0;"><u>Personal & Family Psychiatric History</u></p>
<p>Rice, J. P., Reich, T., Bucholz, K., Neuman, R. J., Fishman, R., Rochberg, N., Hesselbrock, V. M., Numberger, J. I., Shuckit, M. A., & Begleiter, H. (1995). Comparison of Direct Interview and Family History Diagnoses of Alcohol Dependence.  <em>Alcoholism: Clinical and Experimental Research</em>, <em>19</em>, 1018-1023. <a href="https://doi.org/10.1111/j.1530-0277.1995.tb00983.x">https://doi.org/10.1111/j.1530-0277.1995.tb00983.x</a></p>

<p style="margin-bottom: 0; padding-bottom: 0;"><u>APA 1/2 Mental Health</u></p>
<ul>
<p>Doss, R. A., &amp; Lowmaster, S. E. (2022). Validation of the DSM-5 Level 1 Cross-Cutting Symptom Measure in a Community  Sample. <em>Psychiatry Research</em>, <em>318</em>, 114935. <a href="https://doi.org/10.1016/j.psychres.2022.114935">https://doi.org/10.1016/j.psychres.2022.114935</a></p>
<p>Estabrook, R., Massey, S. H., Clark, C. A. C., Burns, J. L., Mustanski, B. S., Cook, E. H., O’Brien, T. C., Makowski, B., Espy, K. A., & Wakschlag, L. S. (2016). Separating family-level and direct exposure effects of smoking during pregnancy on offspring externalizing symptoms: Bridging the behavior genetic and behavior teratologic divide. Behavior Genetics, 46(3), 389–402. <a href="https://doi.org/10.1007/s10519-015-9762-2">https://doi.org/10.1007/s10519-015-9762-2</a></p>
<p>Massey, S. H., Mroczek, D. K., Burns, J. L., Clark, C. A. C., Espy, K. A., & Wakschlag, L. S. (2018). Positive parenting behaviors in women who spontaneously quit smoking during pregnancy: Clues to putative targets for preventive interventions. Neurotoxicology and Teratology, 67, 18–24.<a href="https://doi.org/10.1016/j.ntt.2018.02.003">https://doi.org/10.1016/j.ntt.2018.02.003</a></p>
<p>Massey, S. H., Reiss, D., Neiderhiser, J. M., Leve, L. D., Shaw, D. S., & Ganiban, J. M. (2016). Maternal personality traits associated with patterns of prenatal smoking and exposure: Implications for etiologic and prevention research. Neurotoxicology and Teratology, 53, 48–54. <a href="https://doi.org/10.1016/j.ntt.2015.11.010">https://doi.org/10.1016/j.ntt.2015.11.010</a></p>
<p>Roche, M. J., Pincus, A. L., &amp; Cole, P. E. (2019). Linking dimensions and dynamics in psychopathology research: An example using DSM-5 instruments. <em>Journal of Research in Personality</em>, <em>82</em>, 103852. <a href="https://doi.org/https://doi.org/10.1016/j.jrp.2019.103852">https://doi.org/https://doi.org/10.1016/j.jrp.2019.103852</a></p>

<p style="margin-bottom: 0; padding-bottom: 0;"><u>EPDS</u></p>
<p>Cox, J. L., Holden, J. M., &amp; Sagovsky, R. (1987). Detection of postnatal depression . Development of the 10-item Edinburgh Postnatal Depression Scale. <em>British Journal of Psychiatry</em>, <em>150</em>, 782–786. <a href="https://doi.org/10.1192/bjp.150.6.782">https://doi.org/10.1192/bjp.150.6.782</a></p>
</div>

